Immunoadjuvant Properties of the Rho Activating Factor CNF1 in Prophylactic and Curative Vaccination against Leishmania infantum.
There is a need to develop new effective immunoadjuvants for prophylactic or therapeutic vaccines against intracellular pathogens. The activation of Rho GTPases by bacterial cytotoxic necrotizing factor 1 (CNF1) elicits humoral protective responses against protein antigens. Here, we set out to inves...
Main Authors: | Grégory Michel, Bernard Ferrua, Patrick Munro, Laurent Boyer, Nassim Mathal, Daniel Gillet, Pierre Marty, Emmanuel Lemichez |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4892475?pdf=render |
Similar Items
-
Luciferase-expressing Leishmania infantum allows the monitoring of amastigote population size, in vivo, ex vivo and in vitro.
by: Grégory Michel, et al.
Published: (2011-09-01) -
In vivo involvement of polymorphonuclear neutrophils in Leishmania infantum infection
by: Le Fichoux Yves, et al.
Published: (2001-08-01) -
Escherichia coli α-hemolysin counteracts the anti-virulence innate immune response triggered by the Rho GTPase activating toxin CNF1 during bacteremia.
by: Mamady Diabate, et al.
Published: (2015-03-01) -
Final comments on an interesting taxonomic dilemma: Leishmania infantum versus Leishmania infantum chagasi
by: Filipe Dantas-Torres
Published: (2006-12-01) -
Hydroperoxide metabolism in Leishmania infantum
by: Castro, Helena Maria de Sousa
Published: (2009)